Financial News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
May 16, 2023 at 12:35 PM EDT
The FDA is slated to make a decision on whether to approve Pfizer's shot in August, just before respiratory syncytial virus season in the fall.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
